However, SOD1 and other antioxidant enzymes such as GPX3, SOD3, and CAT only showed a trend for upregulation in dry AMD, which suggests that protective mechanisms (e.g., Nrf2 pathway) are activated with the progression of the disease [55]. The gene discussed is NFE2L2; the disease is dry age related macular degeneration.